Skip to main content UK The UK's free public sector contract intelligence platform. 160,000+ live opportunities from every official UK procurement portal.
PA23 Ready UK Data Daily Updates
BidWriter Found a contract? BidWriter drafts, scores and manages the bid — AI bid writing from your own evidence.
eSourcing OS For buyers. The platform contracting authorities run their tenders, frameworks and DPS on.
See eSourcing OS → 🇺🇸 WinAContract InternationalBidding on US federal & state contracts? Use our American platform:
© 2026 eSourcing Data Ltd · Company No. 16391108 Registered in England & Wales
Data sourced under Crown Copyright from official UK government portals 🇬🇧
Loading contract search results…
Loading contract details…
#2c3e50#3aaee0
Awarded: NHS National Generic Pharmaceuticals Wave 14b | Aspen Pharmacare UK Limited | WinAContract
NHS National Generic Pharmaceuticals Wave 14b Private Sector Award update Closed SME-friendly
Source: Contracts Finder Notice Type: Award update Buyer: ATAMIS LTD Main Category: Goods Procurement Method: Open procedure (above threshold) Tender Status: Closed Estimated Value (ex. VAT):
Award outcome Awarded to (99 suppliers)
Aspen Pharmacare UK Limited GB-CFS-233003
Flexipharm Austrading Limited GB-CFS-215219
Laboratorio Reig Jofre SA GB-CFS-215192
Colonis Pharma Ltd GB-CFS-226310
Consilient Health Ltd GB-CFS-215191
hameln pharma ltd GB-CFS-215188
Galvany Pharma Ltd GB-CFS-255298
Piramal Critical care Limited GB-CFS-181857
Martindale Pharma GB-CFS-255299
Description Invitation to offer for NHS National Generic Pharmaceuticals Wave 14b
Offer reference number: CM/PHG/22/5668
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8months)
Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24 months)
Housekeeping Products (Hospital Only):
DLN & DNW regions 01/10/2023 -31/01/2025 (16 months)
DLS & DNE regions 01/10/2023 - 31/05/2024 (8 months)
Add to pipelineImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Save Alert me Share this contractApplication Deadline
18 April 2023
Closed
Estimated Value
£428,226,984
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation → Release Date: 16 August 2023
Application Deadline: 18 April 2023
Contract Start Date: 30 September 2023
Contract End Date: 30 September 2025
Contract Duration: 2.0 years
Procurement ID (OCID): ocds-b5fd17-b1081409-5829-4aeb-8bff-5dbf01e70c26
Notice Reference: e60c1acf-3d75-4bad-b3c5-d45f289254d5-672388
View Original Notice
Access the full notice on the official portal
Fresenius Kabi Limited
GB-CFS-181853
Amarox Limited GB-CFS-188189
Lundbeck Limited GB-CFS-215217
Stirling Anglian Pharmaceuticals Ltd GB-CFS-209874
Lucane Pharma GB-CFS-215236
GlaxoSmithKline UK Limited GB-CFS-255300
Wockhardt UK Limited GB-CFS-186547
Kent Pharma Ltd GB-CFS-216262
Morningside Pharmaeuticals GB-CFS-216264
Arcadia Pharma Ltd T/A Arcadia Medical GB-CFS-233009
Thornton and Ross Ltd GB-CFS-165045
Milpharm Ltd/aurobinbdo GB-CFS-215224
Accord-UK Ltd GB-CFS-165037
Bowmed Ibisqus Limited GB-CFS-255301
B. Braun Medical Limited GB-CFS-181856
Thea Pharmaceuticals Limited GB-CFS-215199
Neuraxpharm UK Ltd GB-CFS-255302
Esteve Pharmaceuticals Ltd GB-CFS-255303
Manx Healthcare Ltd GB-CFS-215211
CST Pharma Limited GB-CFS-183757
Janssen-Cilag Ltd GB-CFS-165041
Otsuka Pharmaceuticals UK Limited GB-CFS-233019
Ferring Pharmaceuticals Ltd GB-CFS-183751
Teva UK Limited GB-CFS-165044
Bristol Laboratories Limited GB-CFS-255305
Dr.Reddy's Laboratories (UK) Limited GB-CFS-226312
Selective Supplies Ltd. GB-CFS-216266
Day Lewis Medical Ltd GB-CFS-215215
Sun Pharma UK Ltd GB-CFS-232995
FLYNN PHARMA LTD GB-CFS-216267
Glenmark Pharmaceuticals Europe Limited GB-CFS-186544
MSN Laboratories Europe Limited GB-CFS-255307
Aventis Pharma ltd t/a Sanofi GB-CFS-183752
Chiesi Limited GB-CFS-186555
Gerot Lannach UK Ltd GB-CFS-226311
Lupin Healthcare (UK) Limited GB-CFS-215229
medac Pharma LLP GB-CFS-186546
Recordati Pharmaceuticals Ltd GB-CFS-255308
Relonchem Ltd GB-CFS-215220
Baxter Healthcare Ltd GB-CFS-255309
Zentiva Pharma UK Ltd GB-CFS-244141
Mercury Pharmaceuticals Limited GB-CFS-209849
Macure Pharma ApS GB-CFS-215206
Aspire Pharma Limited GB-CFS-226313
Aguettant Ltd GB-CFS-209853
Beaumont Pharma Ltd GB-CFS-255311
Panpharma UK Limited GB-CFS-233002
Roma Pharmaceuticals Limited GB-CFS-216265
Roche Products Ltd GB-CFS-215212
Ridge Pharma GB-CFS-186552
MIP Pharma GmbH GB-CFS-215238
Takeda UK Ltd GB-CFS-183750
Novartis Pharmaceuticals UK Ltd GB-CFS-165042
Norgine Pharmaceuticals Limited GB-CFS-255312
ROVI Biotech Ltd GB-CFS-255313
Bristol Myers Squibb GB-CFS-183746
Perennial Pharma Ltd GB-CFS-255314
Ascend Laboratories UK Ltd GB-CFS-215240
Zista Pharma Ltd GB-CFS-215209
Brown & Burk UK Ltd GB-CFS-255315
Torbay Pharmaceuticals GB-CFS-215222
Tillomed Laboratories ltd GB-CFS-186545
Seacross Pharmaceuticals Ltd GB-CFS-255318
Syri Limited (T/A Thame Laboratories) GB-CFS-215187
RPH Pharmaceuticals AB GB-CFS-215223
Tetris Pharma Lts GB-CFS-233021
GH Pharma Ltd GB-CFS-255319
Sintetica Ltd GB-CFS-255320
GENNISIUM PHARMA GB-CFS-255321
Crescent Pharma Ltd GB-CFS-215225
Kyowa Kirin Ltd GB-CFS-209871
Vantage Pharmaceuticals Ltd GB-CFS-233018
Bausch + Lomb (Pharma) GB-CFS-233013
JCSH Pharma Ltd GB-CFS-255323
Brancaster Pharma Ltd GB-CFS-255324
Award value: £428,226,984 Award decision date: 6 July 2023 Award status: Active